Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CAI
CAI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CAI News
Caris Life Sciences to Report Q1 2026 Financial Results on May 7
2d ago
Newsfilter
Caris Life Sciences to Report Q1 2026 Financial Results on May 7
2d ago
PRnewswire
Caris Partners with UCSF to Advance Precision Oncology
5d ago
PRnewswire
Caris Partners with UCSF to Advance Precision Oncology
5d ago
Newsfilter
Caris Life Sciences Advances Access to Cancer Clinical Trials Nationwide
Apr 15 2026
PRnewswire
Caris Life Sciences Advances Access to Cancer Clinical Trials Nationwide
Apr 15 2026
Newsfilter
Caris Launches AI-Driven NSCLC Treatment Selection Signature
Apr 08 2026
PRnewswire
Caris Launches AI-Driven Molecular Insights for Lung Cancer Treatment
Apr 08 2026
Newsfilter
Caris Launches Advanced Whole Genome Sequencing Technology
Apr 02 2026
PRnewswire
Caris Launches Advanced Whole Genome and Transcriptome Sequencing Technology
Apr 02 2026
Newsfilter
Caris Life Sciences Announces Achieve 1 Study Results for Early Cancer Detection
Mar 31 2026
PRnewswire
Caris Life Sciences Announces Achieve 1 Study Results
Mar 31 2026
Newsfilter
Caris Life Sciences Introduces New AI Signatures for Cancer Risk Assessment
Mar 26 2026
PRnewswire
Caris Life Sciences Introduces New AI Signatures for Cancer Risk Assessment
Mar 26 2026
Newsfilter
Caris Life Sciences to Present Six Studies at AACR Annual Meeting
Mar 25 2026
PRnewswire
Caris Life Sciences to Present Six Studies at AACR Annual Meeting
Mar 25 2026
Newsfilter
Show More News
